Listed

Creative Medical Technology Holdings, Inc.: Form 10-Q for the period ended Jun 30, 2020

Filed with the SEC on Aug 14, 2020 and accepted by EDGAR at Aug 14, 2020, 16:31 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-04-01 to 2020-06-30$27.9kus-gaap:Revenues
Revenue6 months2020-01-01 to 2020-06-30$70.0kus-gaap:Revenues
Cost of revenue3 months2020-04-01 to 2020-06-30$10.8kus-gaap:CostOfRevenue
Cost of revenue6 months2020-01-01 to 2020-06-30$25.0kus-gaap:CostOfRevenue
Gross profit3 months2020-04-01 to 2020-06-30$17.1kus-gaap:GrossProfit
Gross profit6 months2020-01-01 to 2020-06-30$45.0kus-gaap:GrossProfit
Selling, general and administrative3 months2020-04-01 to 2020-06-30$214.9kus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2020-01-01 to 2020-06-30$561.1kus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2020-04-01 to 2020-06-30−$214.3kus-gaap:OperatingIncomeLoss
Operating income6 months2020-01-01 to 2020-06-30−$549.3kus-gaap:OperatingIncomeLoss
Interest expense3 months2020-04-01 to 2020-06-30$297.8kus-gaap:InterestExpense
Interest expense6 months2020-01-01 to 2020-06-30$621.0kus-gaap:InterestExpense
Net income3 months2020-04-01 to 2020-06-30−$1.8mus-gaap:NetIncomeLoss
Net income6 months2020-01-01 to 2020-06-30$1.9mus-gaap:NetIncomeLoss
Diluted EPS3 months2020-04-01 to 2020-06-30−$0.01us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2020-01-01 to 2020-06-30$0.00us-gaap:EarningsPerShareDiluted
Basic EPS3 months2020-04-01 to 2020-06-30−$0.01us-gaap:EarningsPerShareBasic
Basic EPS6 months2020-01-01 to 2020-06-30$0.02us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2020-04-01 to 2020-06-30169,163,555 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2020-01-01 to 2020-06-30960,394,825 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2020-01-01 to 2020-06-30−$317.5kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2020-06-30$37.0kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-06-30$39.6kus-gaap:AssetsCurrent
Total assetsAt period end2020-06-30$442.9kus-gaap:Assets
Current liabilitiesAt period end2020-06-30$4.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-06-30$4.6mus-gaap:Liabilities
Long-term debtAt period end2020-06-30$1.4mus-gaap:LongTermDebt
Shareholders' equityAt period end2020-06-30−$4.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001477932-20-004986. Last ingested by Listed: Nov 14, 2026, 19:08 ET. Listed shows no prices and gives no investment advice.